Company Filing History:
6 out of 93 
2 out of 14 Years Active: 1999-2009
Title: Innovations of Dominique Latinne
Introduction
Dominique Latinne is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of six patents to his name, Latinne's work focuses on antibodies and their applications in preventing immune responses in human patients.
Latest Patents
One of his latest patents is a composition comprising the LO-CD2a antibody. This invention relates to a LO-CD2a antibody and methods of using such antibodies or molecules that bind to the same epitope to prevent and inhibit an immune response in human patients. The administration of an effective amount of the LO-CD2a antibody can prevent or inhibit graft rejection, graft versus host disease, or autoimmune disease. Another significant patent is the method of treatment with the anti-CD2 antibody LO-CD2b. This monoclonal antibody binds to baboon and human CD2, and it may be employed to prevent and inhibit an immune response in human patients, particularly when the immune response is mediated by the activation and proliferation of T-cells or natural killer cells.
Career Highlights
Throughout his career, Latinne has worked with esteemed organizations such as Université Catholique de Louvain and Biotransplant, Inc. His work in these institutions has allowed him to advance his research and contribute to the development of innovative treatments in immunology.
Collaborations
Dominique Latinne has collaborated with notable colleagues, including Herve Bazin and Ruth A Kaplan. These collaborations have further enriched his research and innovations in the field.
Conclusion
Dominique Latinne's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in medical treatments and therapies.